Rhythm Pharmaceuticals CFO Sells Shares

During a recent transaction on December 6, 2023, Hunter Smith, the Chief Financial Officer of Rhythm Pharmaceuticals Inc., executed a substantial sale of company shares. Smith’s disposal of 27,026 shares of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) has garnered attention from both investors and market analysts.

Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in developing and commercializing therapies for rare genetic disorders associated with obesity.

Hunter Smith currently holds the role of CFO at Rhythm Pharmaceuticals Inc., contributing a wealth of experience in financial management and strategic planning to the organization. As CFO, Smith oversees the company’s financial operations, including financial reporting, risk management, and investment strategies. His responsibilities are integral to steering the company’s financial health and growth.

The recent sale of 27,026 shares by Hunter Smith aligns with a larger trend of insider trading activities within Rhythm Pharmaceuticals Inc. Over the past year, Smith has sold a total of 53,513 shares without making any purchases. Analyzing the overall insider transaction history for Rhythm Pharmaceuticals Inc. over the past year reveals no insider buys against 27 insider sells. The company’s stock traded at $38.72 on the day of Smith’s sale, reflecting a market capitalization of $2.243 billion.

Have you read?
EXCLUSIVE: The Top 10 F1 drivers of 2023.
Report: Jordan Citizenship by Investment Programme, 2023.
Report: Malta Citizenship by Investment Programme, 2023.
Report: Saint Lucia Citizenship by Investment Programme, 2023.
Report: St Kitts and Nevis Citizenship by Investment Programme, 2023.
Report: Türkiye Citizenship by Investment Programme, 2023.